APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Haloperidol

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Haloperidol Industry Growth and Trends Forecast to 2032

Report ID 173996900127 December 202593 pages

Choose your research edition.

Industry ResearchHaloperidol Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Haloperidol Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Haloperidol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Haloperidol Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Haloperidol Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Haloperidol market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Haloperidol is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Haloperidol is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Haloperidol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Haloperidol include Teva, Sandoz, Mylan, Zydus, Gland Pharma and Fresenius Kabi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Haloperidol market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Haloperidol market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Haloperidol market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Haloperidol.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Haloperidol market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Haloperidol Market by Company

Teva

Sandoz

Mylan

Zydus

Gland Pharma

Fresenius Kabi

Haloperidol Segment by Type

Oral

Injection

Haloperidol Segment by Application

Mental Disease

Others

Haloperidol Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Haloperidol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Haloperidol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Haloperidol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Haloperidol manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Haloperidol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Table 2. Major Company of Injection Table 3. Global Haloperidol Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Haloperidol Sales by Type (2021-2026) & (Tons) Table 5. Global Haloperidol Sales Market Share in Volume by Type (2021-2026) Table 6. Global Haloperidol Sales by Type (2021-2026) & (US$ Million) Table 7. Global Haloperidol Sales Market Share in Value by Type (2021-2026) Table 8. Global Haloperidol Price by Type (2021-2026) & (US$/Ton) Table 9. Global Haloperidol Sales by Type (2027-2032) & (Tons) Table 10. Global Haloperidol Sales Market Share in Volume by Type (2027-2032) Table 11. Global Haloperidol Sales by Type (2027-2032) & (US$ Million) Table 12. Global Haloperidol Sales Market Share in Value by Type (2027-2032) Table 13. Global Haloperidol Price by Type (2027-2032) & (US$/Ton) Table 14. North America Haloperidol Sales by Type (2021-2026) & (Tons) Table 15. North America Haloperidol Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Haloperidol Sales by Type (2021-2026) & (Tons) Table 17. Europe Haloperidol Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Haloperidol Sales by Type (2021-2026) & (Tons) Table 19. Asia-Pacific Haloperidol Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Haloperidol Sales by Type (2021-2026) & (Tons) Table 21. Latin America Haloperidol Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Haloperidol Sales by Type (2021-2026) & (Tons) Table 23. Middle East and Africa Haloperidol Sales by Type (2021-2026) & (US$ Million) Table 24. Haloperidol Industry Trends Table 25. Haloperidol Industry Drivers Table 26. Haloperidol Industry Opportunities and Challenges Table 27. Haloperidol Industry Restraints Table 28. Global Haloperidol Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Haloperidol Revenue Market Share by Company (2021-2026) Table 30. Global Haloperidol Sales by Company (2021-2026) & (Tons) Table 31. Global Haloperidol Sales Share by Company (2021-2026) Table 32. Global Haloperidol Market Price by Company (2021-2026) & (US$/Ton) Table 33. Global Haloperidol Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Haloperidol Major Company Production Sites and Headquarters Table 35. Global Haloperidol Company, Product Type & Application Table 36. Global Haloperidol Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Haloperidol by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Haloperidol Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Haloperidol Sales by Region (2021-2026) & (Tons) Table 41. Global Haloperidol Sales Market Share in Volume by Region (2021-2026) Table 42. Global Haloperidol Sales by Region (2021-2026) & (US$ Million) Table 43. Global Haloperidol Sales Market Share in Value by Region (2021-2026) Table 44. Global Haloperidol Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Global Haloperidol Sales by Region (2027-2032) & (Tons) Table 46. Global Haloperidol Sales Market Share in Volume by Region (2027-2032) Table 47. Global Haloperidol Sales by Region (2027-2032) & (US$ Million) Table 48. Global Haloperidol Sales Market Share in Value by Region (2027-2032) Table 49. Global Haloperidol Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 50. Global Haloperidol Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Haloperidol Sales by Application (2021-2026) & (Tons) Table 52. Global Haloperidol Sales Market Share in Volume by Application (2021-2026) Table 53. Global Haloperidol Sales by Application (2021-2026) & (US$ Million) Table 54. Global Haloperidol Sales Market Share in Value by Application (2021-2026) Table 55. Global Haloperidol Price by Application (2021-2026) & (US$/Ton) Table 56. Global Haloperidol Sales by Application (2027-2032) & (Tons) Table 57. Global Haloperidol Sales Market Share in Volume by Application (2027-2032) Table 58. Global Haloperidol Sales by Application (2027-2032) & (US$ Million) Table 59. Global Haloperidol Sales Market Share in Value by Application (2027-2032) Table 60. Global Haloperidol Price by Application (2027-2032) & (US$/Ton) Table 61. North America Haloperidol Sales by Application (2021-2026) & (Tons) Table 62. North America Haloperidol Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Haloperidol Sales by Application (2021-2026) & (Tons) Table 64. Europe Haloperidol Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Haloperidol Sales by Application (2021-2026) & (Tons) Table 66. Asia-Pacific Haloperidol Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Haloperidol Sales by Application (2021-2026) & (Tons) Table 68. Latin America Haloperidol Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Haloperidol Sales by Application (2021-2026) & (Tons) Table 70. Middle East and Africa Haloperidol Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Company Information Table 72. Teva Business Overview Table 73. Teva Haloperidol Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Teva Haloperidol Product Portfolio Table 75. Teva Recent Development Table 76. Sandoz Company Information Table 77. Sandoz Business Overview Table 78. Sandoz Haloperidol Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Sandoz Haloperidol Product Portfolio Table 80. Sandoz Recent Development Table 81. Mylan Company Information Table 82. Mylan Business Overview Table 83. Mylan Haloperidol Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Mylan Haloperidol Product Portfolio Table 85. Mylan Recent Development Table 86. Zydus Company Information Table 87. Zydus Business Overview Table 88. Zydus Haloperidol Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Zydus Haloperidol Product Portfolio Table 90. Zydus Recent Development Table 91. Gland Pharma Company Information Table 92. Gland Pharma Business Overview Table 93. Gland Pharma Haloperidol Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Gland Pharma Haloperidol Product Portfolio Table 95. Gland Pharma Recent Development Table 96. Fresenius Kabi Company Information Table 97. Fresenius Kabi Business Overview Table 98. Fresenius Kabi Haloperidol Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Fresenius Kabi Haloperidol Product Portfolio Table 100. Fresenius Kabi Recent Development Table 101. North America Haloperidol Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 102. North America Haloperidol Sales by Country (2021-2026) & (Tons) Table 103. North America Haloperidol Sales Market Share by Country (2021-2026) Table 104. North America Haloperidol Sales Forecast by Country (2027-2032) & (Tons) Table 105. North America Haloperidol Sales Market Share Forecast by Country (2027-2032) Table 106. North America Haloperidol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Haloperidol Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Haloperidol Market Share by Country (2021-2026) Table 109. North America Haloperidol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Haloperidol Market Share Forecast by Country (2027-2032) Table 111. Europe Haloperidol Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 112. Europe Haloperidol Sales by Country (2021-2026) & (Tons) Table 113. Europe Haloperidol Sales Market Share by Country (2021-2026) Table 114. Europe Haloperidol Sales Forecast by Country (2027-2032) & (Tons) Table 115. Europe Haloperidol Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Haloperidol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Haloperidol Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Haloperidol Market Share by Country (2021-2026) Table 119. Europe Haloperidol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Haloperidol Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Haloperidol Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Haloperidol Sales by Country (2021-2026) & (Tons) Table 123. Asia-Pacific Haloperidol Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Haloperidol Sales Forecast by Country (2027-2032) & (Tons) Table 125. Asia-Pacific Haloperidol Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Haloperidol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Haloperidol Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Haloperidol Market Share by Country (2021-2026) Table 129. Asia-Pacific Haloperidol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Haloperidol Market Share Forecast by Country (2027-2032) Table 131. Latin America Haloperidol Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 132. Latin America Haloperidol Sales by Country (2021-2026) & (Tons) Table 133. Latin America Haloperidol Sales Market Share by Country (2021-2026) Table 134. Latin America Haloperidol Sales Forecast by Country (2027-2032) & (Tons) Table 135. Latin America Haloperidol Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Haloperidol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Haloperidol Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Haloperidol Market Share by Country (2021-2026) Table 139. Latin America Haloperidol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Haloperidol Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Haloperidol Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Haloperidol Sales by Country (2021-2026) & (Tons) Table 143. Middle East and Africa Haloperidol Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Haloperidol Sales Forecast by Country (2027-2032) & (Tons) Table 145. Middle East and Africa Haloperidol Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Haloperidol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Haloperidol Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Haloperidol Market Share by Country (2021-2026) Table 149. Middle East and Africa Haloperidol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Haloperidol Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Haloperidol Distributors List Table 154. Haloperidol Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Haloperidol Image Figure 2. Global Haloperidol Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Haloperidol Market Size (2021-2032) & (US$ Million) Figure 4. Global Haloperidol Sales (2021-2032) & (Tons) Figure 5. Oral Image Figure 6. Global Oral Sales YoY Growth (2021-2032) & (Tons) Figure 7. Injection Image Figure 8. Global Injection Sales YoY Growth (2021-2032) & (Tons) Figure 9. Global Haloperidol Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Haloperidol Market Share by Type 2025 VS 2032 Figure 11. North America Haloperidol Sales Market Share in Volume by Type in 2025 Figure 12. North America Haloperidol Sales Market Share in Value by Type in 2025 Figure 13. Europe Haloperidol Sales Market Share in Volume by Type in 2025 Figure 14. Europe Haloperidol Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Haloperidol Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Haloperidol Sales Market Share in Value by Type in 2025 Figure 17. Latin America Haloperidol Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Haloperidol Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Haloperidol Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Haloperidol Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Haloperidol Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Mental Disease Image Figure 24. Global Mental Disease Sales YoY Growth (2021-2032) & (Tons) Figure 25. Others Image Figure 26. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 27. Global Haloperidol Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Haloperidol Market Share by Application 2025 VS 2032 Figure 29. North America Haloperidol Sales Market Share in Volume by Application in 2025 Figure 30. North America Haloperidol Sales Market Share in Value by Application in 2025 Figure 31. Europe Haloperidol Sales Market Share in Volume by Application in 2025 Figure 32. Europe Haloperidol Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Haloperidol Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Haloperidol Sales Market Share in Value by Application in 2025 Figure 35. Latin America Haloperidol Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Haloperidol Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Haloperidol Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Haloperidol Sales Market Share in Value by Application in 2025 Figure 39. North America Haloperidol Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 40. North America Haloperidol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Haloperidol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Haloperidol Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Haloperidol Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. Europe Haloperidol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Haloperidol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Haloperidol Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Haloperidol Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Asia-Pacific Haloperidol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Haloperidol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Haloperidol Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Haloperidol Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Latin America Haloperidol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Haloperidol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Haloperidol Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Haloperidol Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Middle East and Africa Haloperidol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Haloperidol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Haloperidol Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Haloperidol Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Haloperidol Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Mental Disease
  • Others
Companies covered
  • Teva
  • Sandoz
  • Mylan
  • Zydus
  • Gland Pharma
  • Fresenius Kabi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Haloperidol Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Haloperidol Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Haloperidol Market by Type
  6. 1.3.1 Oral
  7. 1.3.2 Injection
  8. 1.4 Global Haloperidol Market Size by Type
  9. 1.4.1 Global Haloperidol Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Haloperidol Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Haloperidol Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Haloperidol Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Haloperidol Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Haloperidol Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Haloperidol Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Haloperidol Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Haloperidol Industry Trends
  2. 2.2 Haloperidol Industry Drivers
  3. 2.3 Haloperidol Industry Opportunities and Challenges
  4. 2.4 Haloperidol Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Haloperidol Revenue (2021-2026)
  2. 3.2 Global Top Players by Haloperidol Sales (2021-2026)
  3. 3.3 Global Top Players by Haloperidol Price (2021-2026)
  4. 3.4 Global Haloperidol Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Haloperidol Major Company Production Sites & Headquarters
  6. 3.6 Global Haloperidol Company, Product Type & Application
  7. 3.7 Global Haloperidol Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Haloperidol Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Haloperidol Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Haloperidol Tier 1, Tier 2, and Tier 3
4 Haloperidol Regional Status and Outlook
  1. 4.1 Global Haloperidol Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Haloperidol Historic Market Size by Region
  3. 4.2.1 Global Haloperidol Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Haloperidol Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Haloperidol Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Haloperidol Forecasted Market Size by Region
  7. 4.3.1 Global Haloperidol Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Haloperidol Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Haloperidol Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Haloperidol by Application
  1. 5.1 Haloperidol Market by Application
  2. 5.1.1 Mental Disease
  3. 5.1.2 Others
  4. 5.2 Global Haloperidol Market Size by Application
  5. 5.2.1 Global Haloperidol Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Haloperidol Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Haloperidol Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Haloperidol Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Haloperidol Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Haloperidol Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Haloperidol Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Haloperidol Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Haloperidol Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Haloperidol Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sandoz
  8. 6.2.1 Sandoz Company Information
  9. 6.2.2 Sandoz Business Overview
  10. 6.2.3 Sandoz Haloperidol Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sandoz Haloperidol Product Portfolio
  12. 6.2.5 Sandoz Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Haloperidol Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Haloperidol Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Zydus
  20. 6.4.1 Zydus Company Information
  21. 6.4.2 Zydus Business Overview
  22. 6.4.3 Zydus Haloperidol Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Zydus Haloperidol Product Portfolio
  24. 6.4.5 Zydus Recent Developments
  25. 6.5 Gland Pharma
  26. 6.5.1 Gland Pharma Company Information
  27. 6.5.2 Gland Pharma Business Overview
  28. 6.5.3 Gland Pharma Haloperidol Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Gland Pharma Haloperidol Product Portfolio
  30. 6.5.5 Gland Pharma Recent Developments
  31. 6.6 Fresenius Kabi
  32. 6.6.1 Fresenius Kabi Company Information
  33. 6.6.2 Fresenius Kabi Business Overview
  34. 6.6.3 Fresenius Kabi Haloperidol Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Fresenius Kabi Haloperidol Product Portfolio
  36. 6.6.5 Fresenius Kabi Recent Developments
7 North America by Country
  1. 7.1 North America Haloperidol Sales by Country
  2. 7.1.1 North America Haloperidol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Haloperidol Sales by Country (2021-2026)
  4. 7.1.3 North America Haloperidol Sales Forecast by Country (2027-2032)
  5. 7.2 North America Haloperidol Market Size by Country
  6. 7.2.1 North America Haloperidol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Haloperidol Market Size by Country (2021-2026)
  8. 7.2.3 North America Haloperidol Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Haloperidol Sales by Country
  2. 8.1.1 Europe Haloperidol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Haloperidol Sales by Country (2021-2026)
  4. 8.1.3 Europe Haloperidol Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Haloperidol Market Size by Country
  6. 8.2.1 Europe Haloperidol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Haloperidol Market Size by Country (2021-2026)
  8. 8.2.3 Europe Haloperidol Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Haloperidol Sales by Country
  2. 9.1.1 Asia-Pacific Haloperidol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Haloperidol Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Haloperidol Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Haloperidol Market Size by Country
  6. 9.2.1 Asia-Pacific Haloperidol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Haloperidol Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Haloperidol Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Haloperidol Sales by Country
  2. 10.1.1 South America Haloperidol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Haloperidol Sales by Country (2021-2026)
  4. 10.1.3 South America Haloperidol Sales Forecast by Country (2027-2032)
  5. 10.2 South America Haloperidol Market Size by Country
  6. 10.2.1 South America Haloperidol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Haloperidol Market Size by Country (2021-2026)
  8. 10.2.3 South America Haloperidol Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Haloperidol Sales by Country
  2. 11.1.1 Middle East and Africa Haloperidol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Haloperidol Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Haloperidol Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Haloperidol Market Size by Country
  6. 11.2.1 Middle East and Africa Haloperidol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Haloperidol Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Haloperidol Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Haloperidol Value Chain Analysis
  2. 12.1.1 Haloperidol Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Haloperidol Production Mode & Process
  7. 12.2 Haloperidol Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Haloperidol Distributors
  10. 12.2.3 Haloperidol Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst